Colligan Clinical Diagnostic Lab is cleared to begin testing pediatric patient samples!

After years of dedicated effort, our clinical lab for pediatric cancer has obtained its CLIA license, and will begin using its newly validated next-generation sequencing test to analyze patient samples in the coming months. The goal of the lab is to identify life-saving treatment options for childhood cancer patients using a unique type of RNA analysis that is able to identify druggable pathways and over-expressed genes that traditional DNA analyses miss. We hope this life-saving analysis will eventually become part of a new standard of care for pediatric cancer..